Bronchopulmonary dysplasia

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Respiratory Physiology

Background:

• Bronchopulmonary dysplasia (BPD) is a primary complication of prematurity.
• Historically, BPD involved lung scarring from mechanical ventilation and oxygen toxicity.
• Contemporary BPD reflects arrested lung development, characterized by alveolar simplification and vascular abnormalities.

Purpose of the Study:

• To delineate the evolution of Bronchopulmonary dysplasia definitions and clinical characteristics.
• To highlight the shift from "old" BPD (fibrotic lung disease) to "new" BPD (arrested lung growth).
• To underscore the long-term respiratory and cardiovascular sequelae of BPD.

Main Methods:

• Review of historical and current definitions of Bronchopulmonary dysplasia.
• Analysis of clinical presentation and progression of BPD.
• Examination of associated long-term complications and treatment strategies.

Main Results:

• The definition of BPD has shifted from oxygen dependency at 28 days to mode and duration of respiratory support.
• "New" BPD is characterized by impaired alveolarization and pulmonary vascular dysgenesis.
• Long-term risks include reactive airway disease, asthma, COPD, and pulmonary hypertension.

Conclusions:

• Bronchopulmonary dysplasia represents a spectrum of lung injury and developmental impairment in premature infants.
• Updated definitions aid in classifying BPD severity and guiding management.
• Pulmonary hypertension is a critical complication requiring specific medical and anesthetic considerations.